In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
B.S. in Biological Sciences, Stanford University 1998
Over 20 years of bench experience within academic, corporate, government, and private laboratories in basic biochemistry discovery, microbiology, cancer therapeutics, cardiovascular disease, and other areas. Involved in study design and implementation as well as data analysis.
Many publications within PNAS, JACS, etc. and numerous abstracts within the field of cardiovascular medicine from the SF VAMC via NCIRE and elsewhere.
2015 - John C. Cha. Impostors, Capgras-ians, and reverse Capgras-ians beware.
Citizenship: USA
No comments:
Post a Comment